This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Aug 19;466(7309):909.

doi: 10.1038/466909a.

FDA challenges stem-cell clinic

David Cyranoski

PMID: 20725009
DOI: 10.1038/466909a

FDA challenges stem-cell clinic

David Cyranoski. Nature. 2010.

. 2010 Aug 19;466(7309):909.

doi: 10.1038/466909a.

Author

David Cyranoski

PMID: 20725009
DOI: 10.1038/466909a

No abstract available

PubMed Disclaimer

Similar articles

FDA's claims over stem cells upheld.
Cyranoski D. Cyranoski D. Nature. 2012 Aug 2;488(7409):14. doi: 10.1038/488014a. Nature. 2012. PMID: 22859178 No abstract available.
The Food and Drug Administration, regenerative sciences, and the regulation of autologous stem cell therapies.
von Tigerstrom B. von Tigerstrom B. Food Drug Law J. 2011;66(4):479-506, i. Food Drug Law J. 2011. PMID: 24505826
Rejuvenating Regenerative Medicine Regulation.
Charo RA, Sipp D. Charo RA, et al. N Engl J Med. 2018 Feb 8;378(6):504-505. doi: 10.1056/NEJMp1715736. Epub 2018 Jan 10. N Engl J Med. 2018. PMID: 29320637 No abstract available.
Regulating autologous adult stem cells: the FDA steps up.
Lysaght T, Campbell AV. Lysaght T, et al. Cell Stem Cell. 2011 Nov 4;9(5):393-6. doi: 10.1016/j.stem.2011.09.013. Cell Stem Cell. 2011. PMID: 22056136 Review.
From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
Knoepfler PS. Knoepfler PS. Adv Drug Deliv Rev. 2015 Mar;82-83:192-6. doi: 10.1016/j.addr.2014.12.001. Epub 2014 Dec 7. Adv Drug Deliv Rev. 2015. PMID: 25489841 Free PMC article. Review.

See all similar articles

Cited by

Clinical use of autologous cell-based therapies in an evolving regulatory landscape: A survey of patient experiences and perceptions.
Ogbogu U, Case N. Ogbogu U, et al. F1000Res. 2024 Aug 27;12:1165. doi: 10.12688/f1000research.141002.2. eCollection 2023. F1000Res. 2024. PMID: 39430869 Free PMC article.
The pluralization of the international: Resistance and alter-standardization in regenerative stem cell medicine.
Rosemann A, Chaisinthop N. Rosemann A, et al. Soc Stud Sci. 2016 Feb;46(1):112-39. doi: 10.1177/0306312715619783. Soc Stud Sci. 2016. PMID: 26983174 Free PMC article.
The commercialization of university-based research: Balancing risks and benefits.
Caulfield T, Ogbogu U. Caulfield T, et al. BMC Med Ethics. 2015 Oct 14;16(1):70. doi: 10.1186/s12910-015-0064-2. BMC Med Ethics. 2015. PMID: 26464028 Free PMC article. Review.
Recent developments in health care law: culture and controversy.
Berry RM, Bliss L, Caley S, Lombardo PA, Wolf LE. Berry RM, et al. HEC Forum. 2013 Mar;25(1):1-24. doi: 10.1007/s10730-012-9203-z. HEC Forum. 2013. PMID: 23180091
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products.
Moll G, Ankrum JA, Olson SD, Nolta JA. Moll G, et al. Stem Cells Transl Med. 2022 Mar 3;11(1):2-13. doi: 10.1093/stcltm/szab005. Stem Cells Transl Med. 2022. PMID: 35641163 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information